BIOLASE Granted Fluid Conditioning Whitening Patent
SAN CLEMENTE, Calif., March 19 /PRNewswire-FirstCall/ -- BIOLASE Technology, Inc. (Nasdaq: BLTI), a medical technology company focused on the dental laser market, today announced that it has been granted a patent with broad claims related to the delivery of whitening agents (focusing on tooth whitening) in the form of atomized fluid particles adapted to work in conjunction with a medical device. The patent has 40 claims, of which 6 are independent and is a continuation of a previous BIOLASE patent, known as the Fluid Conditioning System.
The recently granted patent provides broad coverage for new Fluid Conditioning devices, with applications in cosmetic as well as surgical and therapeutic procedures. The patented technology is applicable to medical or dental devices including lasers, and the main purpose is to complement these areas by applying various fluids to the treatment or surgical site in between or during procedures. The types of fluid covered in this patent are very broad, and include whitening agents, medications, anesthetics, antiseptics, flavors and/or scents. BIOLASE is considering options to commercialize this patent including implementing it with their Waterlase technology and/or licensing agreements with other companies.
In addition to claims related to devices for implementing tooth-whitening procedures, the patent also includes very broad claims related to the use of antiseptic, medicated and flavored fluids. Particularly, the patent has claims related to a device that gives flexibility to the physician in switching from a first modality where, for example, an antiseptic fluid is applied to the tissue site, to a second modality where, for example, a medicated fluid is applied to the tissue site.
BIOLASE also announced it has applied to NASDAQ for listing on the NASDAQ National Market. Management believes, with the advice of consul, that it has more than met the requirements for listing on the NASDAQ National Market; correspondingly the application has been submitted. |
